Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy

The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patien...

Descripción completa

Detalles Bibliográficos
Autor principal: Cafarotti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185017/
https://www.ncbi.nlm.nih.gov/pubmed/32353597
http://dx.doi.org/10.1016/j.jtho.2020.04.015
_version_ 1783526686407524352
author Cafarotti, Stefano
author_facet Cafarotti, Stefano
author_sort Cafarotti, Stefano
collection PubMed
description The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome–coronavirus-2 infection.
format Online
Article
Text
id pubmed-7185017
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Association for the Study of Lung Cancer. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71850172020-04-27 Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy Cafarotti, Stefano J Thorac Oncol Letter to the Editor The coronavirus disease 2019 outbreak is evolving rapidly worldwide. The lungs are the target of the primary infection and patients with lung cancer seem to have a poor prognosis. To our knowledge, this is the first reported investigation of a possible role of interleukin-17 target therapy in patients with lung cancer and concomitant severe acute respiratory syndrome–coronavirus-2 infection. International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2020-07 2020-04-27 /pmc/articles/PMC7185017/ /pubmed/32353597 http://dx.doi.org/10.1016/j.jtho.2020.04.015 Text en © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Cafarotti, Stefano
Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title_full Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title_fullStr Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title_full_unstemmed Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title_short Severe Acute Respiratory Syndrome–Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy
title_sort severe acute respiratory syndrome–coronavirus-2 infection and patients with lung cancer: the potential role of interleukin-17 target therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185017/
https://www.ncbi.nlm.nih.gov/pubmed/32353597
http://dx.doi.org/10.1016/j.jtho.2020.04.015
work_keys_str_mv AT cafarottistefano severeacuterespiratorysyndromecoronavirus2infectionandpatientswithlungcancerthepotentialroleofinterleukin17targettherapy

Ejemplares similares